IN2012CH01309A - - Google Patents
Download PDFInfo
- Publication number
- IN2012CH01309A IN2012CH01309A IN1309CH2012A IN2012CH01309A IN 2012CH01309 A IN2012CH01309 A IN 2012CH01309A IN 1309CH2012 A IN1309CH2012 A IN 1309CH2012A IN 2012CH01309 A IN2012CH01309 A IN 2012CH01309A
- Authority
- IN
- India
- Prior art keywords
- present
- ivabradine
- hydro
- preparation
- provides
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 4
- 238000002360 preparation method Methods 0.000 abstract 3
- HLUKNZUABFFNQS-ZMBIFBSDSA-N ivabradine hydrochloride Chemical compound Cl.C1CC2=CC(OC)=C(OC)C=C2CC(=O)N1CCCN(C)C[C@H]1CC2=C1C=C(OC)C(OC)=C2 HLUKNZUABFFNQS-ZMBIFBSDSA-N 0.000 abstract 2
- BOHZBFAHOBOJOS-ZMBIFBSDSA-N 3-[3-[[(7S)-3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one oxalic acid Chemical class OC(=O)C(O)=O.C1CC2=CC(OC)=C(OC)C=C2CC(=O)N1CCCN(C)C[C@H]1CC2=C1C=C(OC)C(OC)=C2 BOHZBFAHOBOJOS-ZMBIFBSDSA-N 0.000 abstract 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229960003825 ivabradine Drugs 0.000 abstract 1
- 229960000504 ivabradine hydrochloride Drugs 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 239000007962 solid dispersion Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1309CH2012 IN2012CH01309A (enrdf_load_stackoverflow) | 2012-04-02 | 2013-04-01 | |
| PCT/IN2013/000212 WO2013150544A2 (en) | 2012-04-02 | 2013-04-01 | Ivabradine hydrochloride solid dispersion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1309CH2012 IN2012CH01309A (enrdf_load_stackoverflow) | 2012-04-02 | 2013-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012CH01309A true IN2012CH01309A (enrdf_load_stackoverflow) | 2015-06-19 |
Family
ID=49301127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1309CH2012 IN2012CH01309A (enrdf_load_stackoverflow) | 2012-04-02 | 2013-04-01 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2012CH01309A (enrdf_load_stackoverflow) |
| WO (1) | WO2013150544A2 (enrdf_load_stackoverflow) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015145234A1 (en) * | 2014-03-27 | 2015-10-01 | Laboratorio Chimico Internazionale S.P.A. | Ivabradine adsorbates |
| WO2016009314A1 (en) * | 2014-07-18 | 2016-01-21 | Sifavitor S.R.L. | "amorphous mixture of ivabradine and chrysin" |
| CN104230808B (zh) * | 2014-08-22 | 2016-05-18 | 苏州亚宝药物研发有限公司 | 无定形盐酸伊伐布雷定及其制备方法与应用 |
| WO2016102423A1 (en) | 2014-12-22 | 2016-06-30 | Ratiopharm Gmbh | Composition comprising ivabradine in a dissolved form |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2009009659A (es) * | 2007-03-12 | 2009-09-22 | Reddys Lab Ltd Dr | Mesilato de imatinib. |
| RU2473544C2 (ru) * | 2007-05-30 | 2013-01-27 | Инд-Свифт Лабораториз Лимитед | Способ получения ивабрадина гидрохлорида и его полиморфных модификаций |
| SI23290A (sl) * | 2010-02-12 | 2011-08-31 | Krka D.D., Novo Mesto | Nove oblike ivabradin hidroklorida |
| HUP1000245A2 (en) * | 2010-05-07 | 2011-11-28 | Richter Gedeon Nyrt | Industrial process for the production ivabradin salts |
-
2013
- 2013-04-01 IN IN1309CH2012 patent/IN2012CH01309A/en unknown
- 2013-04-01 WO PCT/IN2013/000212 patent/WO2013150544A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013150544A3 (en) | 2013-12-05 |
| WO2013150544A2 (en) | 2013-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279304A (en) | History of cytotoxic benzodiazepines, preparations containing them and their uses | |
| ZA201405101B (en) | "new indolizine compounds, a process for their preparation and pharmaceutical compositions containing them." | |
| IL230218A (en) | Converted atherothecyclic compounds, their preparations and their pharmaceutical preparations | |
| WO2014076712A3 (en) | Lurasidone hydrochloride solid dispersion | |
| IL233154A (en) | Compounds, pharmaceuticals containing them and their uses | |
| SI2379511T1 (sl) | Substituirani diketopiperazinski analogi za uporabo kot sredstva za dostavo zdravil | |
| CA2830549C (en) | Methods and compositions for preparing noribogaine from voacangine | |
| IL221952A (en) | Annotations 2, 3-Dihydro-1h - Indene-1-Il-7,2- Diazaspiro [5.3] Noonan and Pharmaceuticals Containing Them | |
| MX359288B (es) | Forma iv del clorhidrato de ivabradina. | |
| HK1197240A1 (en) | New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities | |
| TW200942524A (en) | Novel aminomethyl benzene derivatives | |
| PL2531505T3 (pl) | Sposób wytwarzania kompleksów 3,7-diaza-bicyklo[3.3.1]nonanu z metalami | |
| MX348393B (es) | Polimorfo de rifaximina y proceso para la preparacion del mismo. | |
| IL217053A0 (en) | Nanoparticulate candesarten cilexetil compositions, process for the preparation thereof and pharmaceutical compositions containing them | |
| WO2014062838A3 (en) | Pkm2 modulators and methods for their use | |
| ZA201401710B (en) | "new administration regime for n-hydroxy-4-{-3-(n,n-dimethylamethyl)benzofurun-2 ylcarbonylamino]ethoxy}benzaminde" | |
| PL2504331T3 (pl) | Związek, jego nowe formy, zawierające je kompozycje farmaceutyczne i sposoby otrzymywania oraz zastosowanie | |
| IN2012CH01309A (enrdf_load_stackoverflow) | ||
| EP2692777A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING A BLOCK COPOLYMER AND A BORIC ACID COMPOUND | |
| IL232058A (en) | Processes for preparing 6 - chloro - 2, 3, 4, 9 - tetrahydro - 1h - carbazole - 1 - carboxamide and its starting materials | |
| UA103996C2 (en) | Ivabradine hydrobromide | |
| WO2014009970A3 (en) | Linagliptin solid dispersion | |
| WO2014115169A3 (en) | Crizotinib solid dispersion | |
| PL2734492T3 (pl) | Sposób wytwarzania 1,1,1-trifluoropropanu | |
| IL218764A (en) | Crystalline lupilopinic acid and the process for its preparation, its uses, and its pharmaceutical preparations |